Regulatory practice and enlightenment of foreign drug frontier technology
YU Ming-li
XIA Wen-jing
JIANG Xiao-meng
WEN Bao-shu
Abstract：The US FDA has responded quickly to the development of frontier pharmaceutical technologies,and is committed to promoting the rapid launch of innovative products to meet the needs of public health to the greatest extent.By analyzing and summarizing the relevant policies,action plans,guidelines and implementation procedures of the US FDA,this paper aims to provide reference for the scientific regulation for these classes of products in China.
Keywords：drugsfrontier technologyregulation
Publication Date：2024-02-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：12( 229-240 )